Clinical Trials Browser

Recruiting × Carcinoma, Transitional Cell × enfortumab vedotin × Clear all

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell

NCT06862219 2026-03-06

A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

Phase 4 Recruiting

100 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT05239624 2026-02-19

Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer

Phase 2 Recruiting

23 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT07221942 2026-02-19

IMPROEV

Phase 2 Recruiting

97 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT05868265 2026-02-17

A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

Phase 2 Recruiting

24 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT06724159 2026-02-17

SOGUG-PRINCIS

Recruiting

500 enrolled

Genitourinary

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urogenital Neoplasms

NCT07183319 2026-02-02

Circulating Tumor DNA Response In Urothelial Cancer

Phase 2 Recruiting

30 enrolled

Genitourinary

Carcinoma, Transitional Cell, Neoplasm Metastasis

NCT06356155 2025-07-29

NEPTUNE

Phase 2 Recruiting

32 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT06493552 2025-04-03

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Phase 2/3 Recruiting

700 enrolled

Genitourinary

Carcinoma, Transitional Cell

Clinical Trials

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer

IMPROEV

A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

SOGUG-PRINCIS

Circulating Tumor DNA Response In Urothelial Cancer

NEPTUNE

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors